THE EFFECTS OF CHEMOTHERAPY INCLUDING CISPLATIN ON VITAMIN-D METABOLISM

被引:18
作者
GAO, Y
SHIMIZU, M
YAMADA, S
OZAKI, Y
ASO, T
机构
[1] TOKYO MED & DENT UNIV,INST MED & DENT ENGN,2-3-10 SURUGADAI,CHIYODA KU,TOKYO 101,JAPAN
[2] TOKYO MED & DENT UNIV,FAC MED,DEPT OBSTET & GYNECOL,TOKYO 113,JAPAN
关键词
1-ALPHA; 25-DIHYDROXYVITAMIN-D(3); CHEMOTHERAPY; CISPLATIN; 1-ALPHA-HYDROXYLASE INHIBITION; FLUOROMETRIC ASSAY;
D O I
10.1507/endocrj.40.737
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Plasma concentrations of three major vitamin D3 metabolites, 25-hydroxyvitamin D3 (25-OHD3), 24R, 25-dihydroxyvitamin D3 (24,25-(OH)2D3), and 1alpha, 25-dihydroxyvitamin D3 (1,25-(OH)2D3), were determined serially in patients with gynecological malignancies treated by chemotherapy which included cisplatin. While 25-OHD3 and 24,25-(OH)2D3 levels did not change regularly, 1,25-(OH)2D3 decreased significantly (50%) after only one or two courses of the treatment in all cases. In concert with declining 1,25-(OH)2D3, the PTH levels increased two or three times. The results were explained by the impairment by cisplatin of mitochondrial function in proximal tubules in the kidney.
引用
收藏
页码:737 / 742
页数:6
相关论文
共 21 条
[1]   SITE OF 1,25(OH)2 VITAMIN-D3 SYNTHESIS IN KIDNEY [J].
BRUNETTE, MG ;
CHAN, M ;
FERRIERE, C ;
ROBERTS, KD .
NATURE, 1978, 276 (5685) :287-289
[2]  
DAUGAARD G, 1990, DAN MED BULL, V37, P1
[3]  
DELUCA HF, 1992, ANN REV BIOCH, V3, P331
[4]  
DENTINO M, 1978, CANCER, V41, P1274, DOI 10.1002/1097-0142(197804)41:4<1274::AID-CNCR2820410410>3.0.CO
[5]  
2-F
[6]  
GHAZARIAN JG, 1974, J BIOL CHEM, V249, P3026
[7]   ISOLATION AND IDENTIFICATION OF 24,25-DIHYDROXYCHOLECALCIFEROL, A METABOLITE OF VITAMIN-D3 MADE IN KIDNEY [J].
HOLICK, MF ;
SUDA, T ;
SCHNOES, HK ;
BOYLE, IT ;
GRAY, RW ;
DELUCA, HF .
BIOCHEMISTRY, 1972, 11 (23) :4251-&
[8]  
JIMENEZ JJ, 1992, CANCER RES, V52, P5123
[9]  
KOZAKAI K, 1990, HORMONE CLIN, V38, P11
[10]  
KUMAR R, 1978, J BIOL CHEM, V253, P3804